{
    "clinical_study": {
        "@rank": "115985", 
        "brief_summary": {
            "textblock": "Step 1: Identification and characterisation of the TREM1L protein from samples already\n      available characterised at the hospital Central of Nancy Step 2: Study of the isoforms of\n      TREM1L in correlation with the prognosis of sepsis, Step 3: implementation of assay methods\n      for TREM1L (ELISA or SUPRA MS) Step 4: Validation of assays for TREM1L and its isoforms in a\n      larger number of subjects (inclusion of samples from Dijon CHU and Besan\u00e7on CHU)"
        }, 
        "brief_title": "Determination of the Nature of the Endogenous Ligand of TREM-1 and Its Use as a New Diagnostic Biomarker in Sepsis", 
        "condition": "Sepsis", 
        "condition_browse": {
            "mesh_term": [
                "Sepsis", 
                "Toxemia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients hospitalised in a Medical Intensive Care unit whatever the reason\n\n          -  written informed consent obtained\n\n        Exclusion Criteria:\n\n          -  patients less than 18 years old or under guardianship, persons without national\n             health insurance."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Blood samples used for this study come from a collection being created as part of the\n        research entitled \"The combined determination STREM-1/PCT/CD64 it allows the diagnosis of\n        sepsis in intensive care\" - No. IDRCB 2009 - A00870-57 and led by Professor Sebastian\n        GIBOT CHU Nancy."
            }
        }, 
        "enrollment": {
            "#text": "0", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01903668", 
            "org_study_id": "Ducoroy PHRC IR 2012"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 17, 2013", 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "overall_status": "Withdrawn", 
        "oversight_info": {
            "authority": "Unspecified"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "plasma concentrations of sTREM-1", 
            "safety_issue": "No", 
            "time_frame": "baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01903668"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Centre Hospitalier Universitaire Dijon", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire Dijon", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "July 2013"
    }
}